ATE445636T1 - Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte - Google Patents

Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte

Info

Publication number
ATE445636T1
ATE445636T1 AT05824259T AT05824259T ATE445636T1 AT E445636 T1 ATE445636 T1 AT E445636T1 AT 05824259 T AT05824259 T AT 05824259T AT 05824259 T AT05824259 T AT 05824259T AT E445636 T1 ATE445636 T1 AT E445636T1
Authority
AT
Austria
Prior art keywords
peptide
synthesis
intermediate products
fragments
peptide fragments
Prior art date
Application number
AT05824259T
Other languages
English (en)
Inventor
Yeun-Kwei Han
David Johnston
Hiralal Khatri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE445636T1 publication Critical patent/ATE445636T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05824259T 2004-12-30 2005-12-22 Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte ATE445636T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64091104P 2004-12-30 2004-12-30
PCT/EP2005/013853 WO2006069728A1 (en) 2004-12-30 2005-12-22 Synthesis of peptide t-20 using peptide intermediate fragments

Publications (1)

Publication Number Publication Date
ATE445636T1 true ATE445636T1 (de) 2009-10-15

Family

ID=36025222

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05824259T ATE445636T1 (de) 2004-12-30 2005-12-22 Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte

Country Status (12)

Country Link
US (1) US20060276624A1 (de)
EP (1) EP1833843B1 (de)
JP (1) JP4886702B2 (de)
KR (1) KR101243013B1 (de)
CN (1) CN101133077B (de)
AT (1) ATE445636T1 (de)
CA (1) CA2592438C (de)
DE (1) DE602005017188D1 (de)
ES (1) ES2332418T3 (de)
IL (1) IL184080A (de)
MX (1) MX2007007917A (de)
WO (1) WO2006069728A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261475A1 (en) * 2004-02-13 2005-11-24 Harvard Medical School Solid-phase capture-release-tag methods for phosphoproteomic analyses
CA2593866C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis of peptide t-1249 using peptide intermediate fragments
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
MX2010006044A (es) * 2007-12-11 2010-06-23 Hoffmann La Roche Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.
CN110372781B (zh) * 2019-07-29 2021-11-16 深圳佳肽生物科技有限公司 恩夫韦肽的制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ254640A (en) * 1992-07-20 1997-04-24 Univ Duke Hiv protein fragments of transmembrane glycoprotein gp41 (dp-107) with antiviral activity and their use
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5817758A (en) * 1995-06-07 1998-10-06 Terrapin Technologies, Inc. P-nitrobenzyl side-chain protection for solid-phase synthesis
WO1999048513A1 (en) * 1998-03-23 1999-09-30 Trimeris, Inc. Methods and compositions for peptide synthesis
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
CA2593866C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis of peptide t-1249 using peptide intermediate fragments

Also Published As

Publication number Publication date
KR101243013B1 (ko) 2013-03-14
DE602005017188D1 (de) 2009-11-26
EP1833843A1 (de) 2007-09-19
CN101133077A (zh) 2008-02-27
CA2592438A1 (en) 2006-07-06
CA2592438C (en) 2013-09-03
EP1833843B1 (de) 2009-10-14
JP2008526698A (ja) 2008-07-24
IL184080A0 (en) 2007-10-31
CN101133077B (zh) 2012-09-05
WO2006069728A1 (en) 2006-07-06
IL184080A (en) 2010-12-30
US20060276624A1 (en) 2006-12-07
JP4886702B2 (ja) 2012-02-29
KR20070103400A (ko) 2007-10-23
MX2007007917A (es) 2007-08-14
ES2332418T3 (es) 2010-02-04

Similar Documents

Publication Publication Date Title
TW200716557A (en) Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
WO2006027705A3 (en) Synthesis of triethylenetetramines
TW200716647A (en) Synthesis of (R)-N-methylnaltrexone
MX2010003599A (es) Intermediarios y metodos para la sintesis de analogos de halicondrina b.
TW200616646A (en) Synthesis of boronic ester and acid compounds
ATE492558T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
MXPA06010097A (es) Inhibidores de dipeptidil peptidasa-iv.
MX2007013632A (es) Procedimientos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo y sus productos intermedios.
ATE492559T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
EA200801571A1 (ru) Композиции, содержащие молекулы ctl4-ig, и способы их получения
ATE507235T1 (de) Synthese von glucagon-ähnlichen peptiden
TW200640914A (en) Novel processes for the preparation of a benzofuran
ATE445636T1 (de) Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
DE602006021327D1 (de) Isochinoline als igf-1r-inhibitoren
IL184081A0 (en) Synthesis using peptide intermediate fragments iii
WO2007103739A3 (en) Methods and compositions related to cyclic peptide synthesis
ATE439371T1 (de) Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
DE602005003922D1 (de) Synthese von spongosin
FR2864830B1 (fr) Procede de synthese sur support solide de composes peptidiques, notamment de composes peptidiques comportant un residu arginine
DE602006008751D1 (de) Synthese von proteaseinhibitorvorstufen
IL178228A (en) Process for the semisynthesis of deserpidine
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
GB0716578D0 (en) Convergent solid phase peptide synthesis by reaction of two fragments bound to solid support

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1833843

Country of ref document: EP